Immunogenicity of allogeneic mesenchymal stem cells

Area of Science:

• Immunology
• Cell Biology
• Regenerative Medicine

Background:

• Mesenchymal stem cells (MSCs) possess immunosuppressive properties and low immunophenotype.
• Their potential for allogeneic transplantation is limited by immunogenicity concerns.

Purpose of the Study:

• To evaluate the in vitro and in vivo immunogenicity of allogeneic rat MSCs.
• To determine if MSCs are protected from cytotoxic lysis and elicit a reduced immune response.

Main Methods:

• In vitro assessment of MSC lysis by cytotoxic T cells.
• In vivo studies involving intravenous injection of allogeneic MSCs and T cells in rats.
• Analysis of T cell activation markers and alloantibody formation.

Main Results:

• Allogeneic MSCs were partially protected against cytotoxic T cells but became susceptible after IFN-γ and IL-1β treatment.
• Intravenous MSC injection induced complement-activating alloantibodies, reducing subsequent MSC survival.
• IFN-γ-stimulated MSCs did not show increased immunogenicity in vivo.

Conclusions:

• Allogeneic MSCs' therapeutic utility may be compromised by their susceptibility to lysis under inflammation and induction of antibody responses.
• Strategies to mitigate MSC immunogenicity are crucial for successful allogeneic transplantation.